StockData
Jushi Holdings Inc. logo

Jushi Holdings Inc. (JUSH) company profile

JUSHOTCMedicinal Chemicals & Botanical ProductsFiscal year ends December 31
Số liệu tài chính tới Q3 năm tài chính 2026, quý kết thúc ngày Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 1/30
$0.49−0.03 (-5.50%)

Close on Oct 19, 2026Market cap $98.11MP/E –Yield –

About Jushi

Medicinal Chemicals & Botanical Products, SIC 2833

The company is a vertically integrated cannabis operator in the United States that cultivates, processes, distributes, and sells cannabis products. Its operations encompass retail dispensaries and wholesale distribution to licensed third parties. The product catalog includes dried flower, pre-rolls, vaporizers, concentrates, infused edibles such as gummies and chocolates, tinctures, capsules, and topicals. It also supplies bulk raw materials to other manufacturers. The company serves both registered medical patients and adult-use recreational consumers.

Geographically, the company maintains operations across eight U.S. states: California, Illinois, Massachusetts, Nevada, New Jersey, Ohio, Pennsylvania, and Virginia. Its retail footprint includes forty-two operational dispensaries, comprising twenty-four medical and eighteen adult-use storefronts primarily under the Beyond Hello, Nature’s Remedy, and NuLeaf banners. The company also operates specialized cultivation and manufacturing facilities in Massachusetts, Nevada, Ohio, Pennsylvania, and Virginia. The provided report does not state the location of the corporate headquarters.

Summary of the business section of Jushi's latest annual report, written by StockData.

Company profile

Company

Legal name
Jushi Holdings Inc.
Headquarters
Boca Raton, FL
Address
301 Yamato Road, Suite 3250 33431
Phone
(561) 617-9100
Employees
1,288, Dec 31, 2025
Industry
Medicinal Chemicals & Botanical Products
Incorporated in
A1
Fiscal year ends
December 31
Auditor
Macias Gini & OConnell LLP, Irvine, California

Stock & identifiers

Ticker
JUSH
Exchange
OTC
IPO date
Jun 18, 2019
Shares outstanding
200M, Oct 22, 2026
Public float
$59.40M, Jun 30, 2025
Filer category
Non-accelerated filer<br>Smaller reporting company<br>Emerging growth company
SEC CIK
1909747
CUSIP
48214U104
ISIN
CA48214U1049
FIGI
BBG00PGGBDN5
Share class FIGI
BBG001T0NHJ2
EIN
98-1547061

Executives and directors

Officers and directors who filed ownership reports (Forms 3, 4, 5) in the last two years

NamePositionShares owned
James CacioppoChief Executive Officer, Director16,938,283
Louis Jon BarackPresident2,928,773
Michelle O. MosierChief Financial Officer147,733
Benjamin CrossDirector239,080
Stephen MonroeDirector153,684
Bill WaffordDirector–
Marina HahnDirector17,301

Executive compensation, fiscal 2025

Summary compensation table from the latest proxy statement

ExecutiveSalaryBonusOption awardsOtherTotalvs. prior year
James Cacioppo
Chief Executive Officer
$1.05M$1.80M–$19.41K$2.87M-19%
Louis Jonathan Barack
President, Chief Revenue Officer and Corporate Secretary
$450.02K$360.00K$188.86K$35.55K$1.03M+12%
Michelle Mosier
Chief Financial Officer and Chief Accounting Officer
$425.02K$212.50K$113.32K$18.77K$769.60K+8%

Stock and option awards are grant-date fair values, not realized pay. “Other” includes pension value changes and all other compensation. Source proxy statement.

Employees

Headcount reported in annual reports

“As of December 31, 2025, we had 1,288 employees.”

Corporate history

Events identified from SEC filings

DateEventDetails
Mar 15, 2024Late filingNotification of late filing
Apr 25, 2023Auditor changeChange in certifying accountant (8-K Item 4.01)
Mar 31, 2023Late filingNotification of late filing
Nov 15, 2022Late filingNotification of late filing

See a number that looks wrong?